Ratings CareNet, Inc.

Equities

2150

JP3277550004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
560 ^JPY	-3.95%		0.00%	-48.95%

Feb. 16	CareNet's Profit Down 18% in Fiscal 2023	MT
Feb. 15	CareNet, Inc. Announces Dividend for the year ended December 31, 2023, Payable on March 27, 2024	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

The group's high margin levels account for strong profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
CARENET, INC.	-48.95%	159M	-
TENCENT HOLDINGS LIMITED	+18.66%	414B	B
NETFLIX, INC.	+15.27%	242B	D+
UBER TECHNOLOGIES, INC.	+12.15%	144B	A-
AIRBNB, INC.	+20.63%	104B	C-
PROSUS N.V.	+17.19%	83.87B	B+
SPOTIFY TECHNOLOGY S.A.	+54.11%	57.64B	B-
DOORDASH, INC.	+33.59%	53.37B	C+
COSTAR GROUP, INC.	+6.02%	37.83B	B
NASPERS LIMITED	+15.88%	34.11B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes